Distribution of micafungin in the tissue fluids of patients with invasive fungal infections

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Ernst-Rüdiger Kuse, Ploenchan Chetchotisakd, Clóvis Arns da Cunha et al. · The Lancet · 2007 · 689 citations

Life Sciences, Infectious Diseases, Microbiology +17

In Vitro Activities of a New Lipopeptide Antifungal Agent, FK463, against a Variety of Clinically Important Fungi

Shuichi Tawara, Fumiaki Ikeda, Katsuyuki Maki et al. · Antimicrobial Agents and Chemotherapy · 2000 · 311 citations

Life Sciences, Microbiology, Pharmacology +17

A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis

N. T. E. De Wet, A J Bester, J. Viljoen et al. · Alimentary Pharmacology & Therapeutics · 2005 · 146 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Compartmental Pharmacokinetics and Tissue Distribution of the Antifungal Echinocandin Lipopeptide Micafungin (FK463) in Rabbits

Andreas H. Groll, Diana Mickiene, Vidmantas Petraitis et al. · Antimicrobial Agents and Chemotherapy · 2001 · 131 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin

Shunji Takakura · Journal of Antimicrobial Chemotherapy · 2004 · 117 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17